Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study

npj Parkinson’s Disease, published online 23 November 2023 In this article the wrong Table appeared as Table 3.; the Table should have appeared as shown below. The original article has been corrected. The following text that describes data from the previous version of Table 3 has also been removed: “Compared to severe (6.4?±?4.7) and risk (4.4?±?4.9) variant carriers, the mild (1.7?±?1.4) variant carriers show a significantly shorter disease duration (Table 3).” (Table presented.) Features All pathogenic variants (n?=?67) Severe (n?=?21) Mild (n?=?7) Risk (n?=?39) Non carriers (n?=?554) AAA, m... Mehr ...

Verfasser: Pachchek, Sinthuja
Landoulsi, Zied
Pavelka, Lukas
Schulte, Claudia
Buena-Atienza, Elena
Gross, Caspar
Hauser, Ann Kathrin
Reddy Bobbili, Dheeraj
Casadei, Nicolas
May, Patrick
Krüger, Rejko
Acharya, Geeta
Aguayo, Gloria
Alexandre, Myriam
Ali, Muhammad
Ammerlann, Wim
Arena, Giuseppe
Balling, Rudi
Bassis, Michele
Batutu, Roxane
Beaumont, Katy
Becker, Regina
Bellora, Camille
Berchem, Guy
Berg, Daniela
Bisdorff, Alexandre
Boussaad, Ibrahim
Bouvier, David
Brockmann, Kathrin
Calmes, Jessica
Castillo, Lorieza
Contesotto, Gessica
De Bremaeker, Nancy
Diederich, Nico
Dondelinger, Rene
E. Ramia, Nancy
Esteves, Daniela
Fagherazzi, Guy
Ferrand, Jean Yves
Frauenknecht, Katrin
Gantenbein, Manon
Gasser, Thomas
Gawron, Piotr
Ghosh, Soumyabrata
Giraitis, Marijus
Glaab, Enrico
Goergen, Martine
Gómez De Lope, Elisa
Graas, Jérôme
Hanff, Anne Marie
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: Pachchek , S , Landoulsi , Z , Pavelka , L , Schulte , C , Buena-Atienza , E , Gross , C , Hauser , A K , Reddy Bobbili , D , Casadei , N , May , P , Krüger , R , Acharya , G , Aguayo , G , Alexandre , M , Ali , M , Ammerlann , W , Arena , G , Balling , R , Bassis , M , Batutu , R , Beaumont , K , Becker , R , Bellora , C , Berchem , G , Berg , D , Bisdorff , A , Boussaad , I , Bouvier , D , Brockmann , K , Calmes , J , Castillo , L , Contesotto , G , De Bremaeker , N , Diederich , N , Dondelinger , R , E. Ramia , N , Esteves , D , Fagherazzi , G , Ferrand , J Y , Frauenknecht , K , Gantenbein , M , Gasser , T , Gawron , P , Ghosh , S , Giraitis , M , Glaab , E , Goergen , M , Gómez De Lope , E , Graas , J , Hanff , A M & NCER-PD Consortium 2023 , ' Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study ' , npj Parkinson's Disease , vol. 9 , no. 1 , 168 . https://doi.org/10.1038/s41531-023-00613-x
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29106539
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://cris.maastrichtuniversity.nl/en/publications/d929ad22-4ab1-4dac-98ce-71755d617c64

npj Parkinson’s Disease, published online 23 November 2023 In this article the wrong Table appeared as Table 3.; the Table should have appeared as shown below. The original article has been corrected. The following text that describes data from the previous version of Table 3 has also been removed: “Compared to severe (6.4?±?4.7) and risk (4.4?±?4.9) variant carriers, the mild (1.7?±?1.4) variant carriers show a significantly shorter disease duration (Table 3).” (Table presented.) Features All pathogenic variants (n?=?67) Severe (n?=?21) Mild (n?=?7) Risk (n?=?39) Non carriers (n?=?554) AAA, mean (SD) 66.5 (±10.2) [OR?=?0.31; p?=?0.3977] 65.1 (±10.2) [OR?=?0.08; p?=?0.292] 67.1 (±15.6) [OR?=?0.59; p?=?0.8959] 67.1 (±9.2) [OR?=?0.57; p?=?0.7512] 67.6 (±10.7) Sex, Male n (%) 40 (59.7%) [OR?=?0.71; p?=?0.1912] 13 (61.9%) [OR?=?0.78; p?=?0.5795] 5 (71.4%) [OR?=?1.19; p?=?0.8336] 22 (56.4%) [OR?=?0.62; p?=?0.151] 375 (67.7%) AAO, mean (SD) 61.6 (±11.5) [OR?=?0.35; p?=?0.484] 58.6 (±13.1) [OR?=?0.02; p?=?0.1158] 65.4 (±17.0) [OR?=?16.16; p?=?0.5308] 62.5 (±9.3) [OR?=?0.9; p?=?0.9548] 62.6 (±11.6) AAO < 45, N (%) 8 (11.9%) [OR?=?1.74; p?=?0.1767] 2 (28.6%) [OR?=?5.14; p?=?0.0549] 1 (2.6%) [OR?=?0.34; p?=?0.2907] 40 (7.2%) Disease Duration, mean (SD) 4.7 (±4.8) [OR?=?0.79; p?=?0.7303] 6.4 (±4.7) [OR?=?4.07; p?=?0.2238] 1.7 (±1.4) [OR?=?0.04; p?=0.0981] 4.4 (±4.9) [OR?=?0.57; p?=?0.5103] 5.0 (±5.2) Family History, N (%) 8 (38.1%) [OR?=?1.8; p?=?0.2001] 2 (28.6% [OR?=?1.17; p?=?0.8508] 15 (38.5%) [OR?=?1.83; p?=?0.0782] 141 (25.5%).